Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification
2011 · Oncogene · 68 citations
https://doi.org/10.1038/onc.2011.111
S
Soichi Fumita
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
802
Citations
13
h-index
16
i10-index
Soichi Fumita is an academic researcher from Kishiwada City Hospital. The author has contributed to research in topics: Gastrointestinal motility and disorders & Lung Cancer Treatments and Mutations & Gastric Cancer Management and Outcomes. The author has an h-index of 13, co-authored 35 publications.
ORCID: 0000-0003-0253-0681Papers by this author
worksFeasibility study of two schedules of sunitinib in combination with pemetrexed in patients with advanced solid tumors
2010 · Investigational New Drugs · 10 citations
https://doi.org/10.1007/s10637-010-9565-5
Retrospective study of definitive therapy for head and neck mucosal melanoma: The RESUME study
2025 · EJC Skin Cancer · 1 citations
https://doi.org/10.1016/j.ejcskn.2025.100736
Effect of Vonoprazan, potassium-competitive acid blocker, on Atezolizumab plus Bevacizumab efficacy in patients with hepatocellular carcinoma: a multicenter retrospective study
2025 · International Journal of Clinical Oncology · 0 citations
https://doi.org/10.1007/s10147-025-02922-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat